Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 220 of 6351
-
New oral pill HPP737 takes on psoriasis in Head-to-Head trial
Disease control CompletedThe goal of this clinical trial is to learn if drug HPP737 works to treat moderate-to-severe plaque psoriasis in adults. It will also learn about the safety of drug HPP737. The main questions it aims to answer are: Does drug HPP737 improve psoriasis severity compared to an activ…
Phase 3 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New cell therapy GT719 targets tough blood cancers in early trial
Disease control Recruiting nowThis study is a prospective single-arm open-labled phase I/II clinical trial, including dose escalation and expansion phase, aims to evaluate the safety, efficacy, and cellular pharmacokinetics of GT719 Injection in relapsed/refractory CD19 positive adult B-cell non Hodgkin lymph…
Phase 1/2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
New PET-MRI tracer could sharpen prostate cancer biopsy accuracy
Diagnosis Recruiting nowThis phase II trial evaluates an imaging technique called 18F-rhPSMA-7.3 positron emission tomography (PET)-multiparametric (mp) magnetic resonance imaging (MRI) in identifying tumor tissue in men suspected to have prostate cancer. This clinical trial also seeks to determine if t…
Phase 2 • Sponsor: Emory University • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New Heart-Lung device could save kids with severe heart failure
Disease control Recruiting nowThere are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two goals are to: 1. To evaluate the safety and effectiveness of the Cardiohelp Device for VA-ECMO (heart-lung support) for …
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Three-Drug attack shrink stomach cancer in the abdomen?
Disease control OngoingFor peritoneal metastatic gastric/gastroesophageal junction adenocarcinoma (cT3-4NanyM1), PD-1 antibody combined with chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) can downstage tumor stage, increase the conversion resection rate, and may improve the long-ter…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can an immunotherapy combo boost tumor shrinkage in a common breast cancer?
Disease control Recruiting nowThe neoadjuvant treatment options commonly used for HR+/HER2- breast cancer are mainly anthracycline sequential or combined with paclitaxel chemotherapy regimens. Several clinical studies have confirmed that albumin paclitaxel is more effective than solvent-based paclitaxel, and …
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a gut microbiome transplant boost fertility in PCOS?
Disease control Recruiting nowThis prospective, two-stage clinical trial aims to evaluate the safety, preliminary efficacy, and reproductive outcomes of oral Fecal Microbiota Transplantation (FMT) freeze-dried capsules in overweight and obese patients with Polyendocrine Metabolic Ovarian Syndrome (PMOS) under…
Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Smarter prostate screening: a new risk score aims to cut unnecessary biopsies
Diagnosis By invitation onlyClarityDX Prostate builds upon the utility of total and free PSA as well as simple clinical features in a decision support model to determine a patient's risk of having clinically significant prostate cancer. The highly accurate ClarityDX Prostate risk score enables clinicians an…
Sponsor: Nanostics • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Can less be more? new trial aims to cut harsh side effects in HPV throat cancer treatment
Disease control Recruiting nowHead and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. Oropharynx SCC (OPSCC) is a common sub-type of HNSCC. Each year, 16,000 new cases of OPSCC are diagnosed in the USA. Most cases of OPSCC (\>90%) are caused by the human papillomavirus (HPV) and are oft…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug combo aims to keep ovarian cancer at bay longer
Disease control Recruiting nowThe main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer getting worse than those who receive standar…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a pill calm the skin symptoms of sarcoidosis?
Disease control Recruiting nowThis study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Phase 2/3 • Sponsor: Priovant Therapeutics, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New hope for kids with MS: Head-to-Head drug trial launches
Disease control Recruiting nowThe purpose of this study is to evaluate the effectiveness, safety, tolerability, drug levels and drug effects of ozanimod compared to fingolimod in children and adolescents with relapsing remitting multiple sclerosis (RRMS).
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hepatitis c pill aims to cut treatment time in half
Disease control OngoingThe purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.
Phase 3 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can 7 days of steroids beat 14 for Alcohol-Related liver disease?
Disease control CompletedAlcohol-associated hepatitis (AAH) is one of the most severe manifestations of the spectrum of alcohol related liver disease (ARLD), with high morbidity and mortality. Currently, corticosteroids are the standard of care for patients with severe AAH, but no consensus exists on the…
Phase 3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a Three-Pronged attack shrink liver tumors in advanced colorectal cancer?
Disease control Recruiting nowBrUOG-430 is a prospective, single-arm, phase 2 trial evaluating yttrium-90 radioembolization in combination with capecitabine and atezolizumab for the treatment of unresectable colorectal cancer liver metastases in individuals who have been treated with two or more lines of syst…
Phase 2 • Sponsor: Brown University • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a protein boost immune recovery after myeloma transplant?
Disease control OngoingThis is a two-arm, open-label, randomized, single-site, pilot study testing the addition of CYT107 following autologous hematopoietic cell transplant (AHCT) in patients with multiple myeloma (MM). The hypothesis of this study is that recombinant human CYT107 can be safely adminis…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could an immune booster keep early lung cancer from returning?
Disease control Recruiting nowThis phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Magnetic brain pulses could offer Drug-Free hope for teen depression
Disease control Recruiting nowThis is a single-site open-label clinical trial of fMRI-guided accelerated intermittent theta burst stimulation. The goal of this clinical trial is to learn if a new form of transcranial magnetic stimulation (TMS)-known generally as accelerated intermittent theta burst stimulatio…
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
A mist of antibiotic could stop a deadly ICU infection
Prevention Recruiting nowVentilator associated pneumonia is the most common manifestation of hospital acquired infections in ICU. The incidence of ventilator-associated pneumonia in patients receiving mechanical ventilation is as high as 20% -71%, which can lead to increased systemic antibiotic use, prol…
Sponsor: Southeast University, China • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
Magic mushroom compound tested for dual relief of chronic pain and depression
Symptom relief Recruiting nowPsilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to assess the feasibility, tolerability, and preliminar…
Phase 2 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC